deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT03740919

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes (PRONTO-Peds)

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes

Sponsor: Eli Lilly and Company

Conditions Type 1 Diabetes Mellitus
Interventions Insulin Degludec Insulin Glargine Insulin Lispro LY900014
Updated 32 times since 2018 Last updated: Dec 23, 2021 Started: Apr 7, 2019 Primary completion: Jul 2, 2021 Completion: Jul 2, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Type 1 Diabetes Mellitus and is currently completed. Eli Lilly and Company leads this study, which shows 32 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

32 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Feb 2022 — Jul 2024 [monthly]

    Completed PHASE3

  5. Sep 2021 — Feb 2022 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

▶ Show 27 earlier versions

  1. Feb 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  2. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  4. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE3

  5. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE3

  6. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE3

  7. Aug 2020 — Sep 2020 [monthly]

    Recruiting PHASE3

  8. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE3

  9. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE3

  10. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE3

  11. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE3

  12. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE3

  13. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE3

  14. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE3

  15. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE3

  16. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  17. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE3

  18. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  19. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

  20. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE3

  21. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  22. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  23. Apr 2019 — May 2019 [monthly]

    Not Yet Recruiting PHASE3

  24. Mar 2019 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE3

  25. Feb 2019 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE3

  26. Jan 2019 — Feb 2019 [monthly]

    Not Yet Recruiting PHASE3

  27. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Ancona, Italy , Atlanta, United States , Aurora, United States , Austin, United States , Baltimore, United States , Barcelona, Spain , Baton Rouge, United States , Beer Yaakov, Israel , Beersheba, Israel and 98 more locations